Ixabepilone: a new active chemotherapy in the treatment of breast cancer

Author： Villanueva Cristian   Vuillemin Antoine Thiery   Demarchi Martin   Bazan Fernando   Chaigneau Loïc   Pivot Xavier  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.5, Iss.2, 2009-03, pp. : 115-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 5, 2015-05 ,pp. : 315-320

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant Chemotherapy for the Treatment of HER2-Positive Early Breast Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 14-17

Karger

Access to resources Recommend Favorite

Hormonal Treatment of Breast Cancer: New Developments

By  

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 501-507

Karger

Access to resources Recommend Favorite

Is Gemcitabine plus Vinorelbine Active in Second-Line Chemotherapy of Metastatic Breast Cancer? A Single-Center Phase 2 Study

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 479-480

Karger

Access to resources Recommend Favorite

Neurotoxicity as a Prognostic Factor in Patients with Metastatic Breast Cancer Treated with Ixabepilone as a First-Line Therapy

By  

Oncology, Vol. 88, Iss. 3, 2014-11 ,pp. : 180-188

Karger

Access to resources Recommend Favorite